"Designing Growth Strategies is in our DNA"

Influenza Vaccine Market Size, Share & Industry Analysis, By Type (Inactivated and Live Attenuated), By Valency (Quadrivalent and Trivalent), By Age Group (Pediatric and Adults), By Distribution Channel (Hospital & Retail Pharmacies, Government Suppliers, and Others), and Regional Forecast, 2024-2032

Last Updated: October 28, 2024 | Format: PDF | Report ID: FBI101896

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
    4. Market Trends
  4. Key Insights
    1. Snapshot of Influenza Vaccine Rate – For Key Countries, 2023
    2. Annual Disease Burden of Influenza – For Key Countries/ Regions, 2022/2023
    3. New Product Launches, By Key Players
    4. Influenza Vaccination Campaigns/Programs Undertaken by Government
    5. Key Industry Developments - Mergers, Acquisitions, and Partnerships
    6. Pricing Analysis – By Key Brand/Key Players, By Key Countries, 2022/2023
    7. Snapshot of Pipeline Analysis of Influenza Vaccines
    8. Impact of COVID-19 on the Market
  5. Global Influenza Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Region
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
  6. North America Influenza Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Valency
      2. Canada
        1. By Valency
  7. Europe Influenza Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. U.K.
        1. By Valency
      2. Germany
        1. By Valency
      3. France
        1. By Valency
      4. Italy
        1. By Valency
      5. Spain
        1. By Valency
      6. Scandinavia
        1. By Valency
      7. Rest of Europe
        1. By Valency
  8. Asia Pacific Influenza Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Japan
        1. By Valency
      2. China
        1. By Valency
      3. India
        1. By Valency
      4. Australia
        1. By Valency
      5. Korea
        1. By Valency
      6. Rest of Asia Pacific
        1. By Valency 
  9. Latin America Influenza Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. Brazil
        1. By Valency
      2. Mexico
        1. By Valency
      3. Rest of Latin America
        1. By Valency 
  10. Middle East & Africa Influenza Vaccines Market Analysis, Insights and Forecast, 2019-2032
    1. Market Analysis, Insights and Forecast – By Type
      1. Inactivated
      2. Live Attenuated
    2. Market Analysis, Insights and Forecast – By Valency
      1. Quadrivalent
      2. Trivalent
    3. Market Analysis, Insights and Forecast – By Age Group
      1. Pediatric
      2. Adults
    4. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital & Retail Pharmacies
      2. Government Suppliers
      3. Others
    5. Market Analysis, Insights and Forecast – By Country/Sub-region
      1. GCC Countries
        1. By Valency 
      2. South Africa
        1. By Valency
      3. Rest of Middle East & Africa
        1. By Valency
  11. Competitive Analysis
    1. Global Market Share Analysis (2023)
    2. Company Profiles
      1. AstraZeneca
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      2. CSL Limited (Seqirus)
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      3. GlaxoSmithKline plc
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      4. Sanofi
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      5. SINOVAC
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      6. BIKEN Co., Ltd.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      7. Abbott
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
      8. Viatris Inc.
        1. Overview
        2. Products
        3. SWOT analysis
        4. Recent Developments
        5. Strategies
        6. Financials (Based on Availability)
Read Less

Figure 01: Global Influenza Vaccine Market Revenue Breakdown (USD billion, %) by Region, 2023 & 2032

Figure 02: Global Influenza Vaccine Market Value Share (%), By Type, 2023 & 2032

Figure 03: Global Influenza Vaccine Market Value Share (%), By Valency, 2023 & 2032

Figure 04: Global Influenza Vaccine Market Value Share (%), By Age Group, 2023 & 2032

Figure 05: Global Influenza Vaccine Market Value Share (%), By Distribution Channel, 2023 & 2032

Figure 06: Global Influenza Vaccine Market Value Share (%), By Region, 2023 & 2032

Figure 07: North America Influenza Vaccine Market Value (USD billion), by Type, 2023 & 2032

Figure 08: North America Influenza Vaccine Market Value Share (%), by Type, 2023

Figure 09: North America Influenza Vaccine Market Value (USD billion), by Valency, 2023 & 2032

Figure 10: North America Influenza Vaccine Market Value Share (%), by Valency, 2023

Figure 11: North America Influenza Vaccine Market Value (USD billion), by Age Group, 2023 & 2032

Figure 12: North America Influenza Vaccine Market Value Share (%), by Age Group, 2023

Figure 13: North America Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 14: North America Influenza Vaccine Market Value Share (%), by Distribution Channel, 2023

Figure 15: North America Influenza Vaccine Market Value (USD billion), by Country, 2023 & 2032

Figure 16: North America Influenza Vaccine Market Value Share (%), by Country, 2023

Figure 17: Europe Influenza Vaccine Market Value (USD billion), by Type, 2023 & 2032

Figure 18: Europe Influenza Vaccine Market Value Share (%), by Type, 2023

Figure 19: Europe Influenza Vaccine Market Value (USD billion), by Valency, 2023 & 2032

Figure 20: Europe Influenza Vaccine Market Value Share (%), by Valency, 2023

Figure 21: Europe Influenza Vaccine Market Value (USD billion), by Age Group, 2023 & 2032

Figure 22: Europe Influenza Vaccine Market Value Share (%), by Age Group, 2023

Figure 23: Europe Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 24: Europe Influenza Vaccine Market Value Share (%), by Distribution Channel, 2023

Figure 25: Europe Influenza Vaccine Market Value (USD billion), by Country, 2023 & 2032

Figure 26: Europe Influenza Vaccine Market Value Share (%), by Country, 2023

Figure 27: Asia Pacific Influenza Vaccine Market Value (USD billion), by Type, 2023 & 2032

Figure 28: Asia Pacific Influenza Vaccine Market Value Share (%), by Type, 2023

Figure 29: Asia Pacific Influenza Vaccine Market Value (USD billion), by Valency, 2023 & 2032

Figure 30: Asia Pacific Influenza Vaccine Market Value Share (%), by Valency, 2023

Figure 31: Asia Pacific Influenza Vaccine Market Value (USD billion), by Age Group, 2023 & 2032

Figure 32: Asia Pacific Influenza Vaccine Market Value Share (%), by Age Group, 2023

Figure 33: Asia Pacific Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 34: Asia Pacific Influenza Vaccine Market Value Share (%), by Distribution Channel, 2023

Figure 35: Asia Pacific Influenza Vaccine Market Value (USD billion), by Country, 2023 & 2032

Figure 36: Asia Pacific Influenza Vaccine Market Value Share (%), by Country, 2023

Figure 37: Latin America Influenza Vaccine Market Value (USD billion), by Type, 2023 & 2032

Figure 38: Latin America Influenza Vaccine Market Value Share (%), by Type, 2023

Figure 39: Latin America Influenza Vaccine Market Value (USD billion), by Valency, 2023 & 2032

Figure 40: Latin America Influenza Vaccine Market Value Share (%), by Valency, 2023

Figure 41: Latin America Influenza Vaccine Market Value (USD billion), by Age Group, 2023 & 2032

Figure 42: Latin America Influenza Vaccine Market Value Share (%), by Age Group, 2023

Figure 43: Latin America Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 44: Latin America Influenza Vaccine Market Value Share (%), by Distribution Channel, 2023

Figure 45: Latin America Influenza Vaccine Market Value (USD billion), by Country, 2023 & 2032

Figure 46: Latin America Influenza Vaccine Market Value Share (%), by Country, 2023

Figure 47: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Type, 2023 & 2032

Figure 48: Middle East & Africa Influenza Vaccine Market Value Share (%), by Type, 2023

Figure 49: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Valency, 2023 & 2032

Figure 50: Middle East & Africa Influenza Vaccine Market Value Share (%), by Valency, 2023

Figure 51: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Age Group, 2023 & 2032

Figure 52: Middle East & Africa Influenza Vaccine Market Value Share (%), by Age Group, 2023

Figure 53: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Distribution Channel, 2023 & 2032

Figure 54: Middle East & Africa Influenza Vaccine Market Value Share (%), by Distribution Channel, 2023

Figure 55: Middle East & Africa Influenza Vaccine Market Value (USD billion), by Country, 2023 & 2032

Figure 56: Middle East & Africa Influenza Vaccine Market Value Share (%), by Country, 2023

Figure 57: Global Influenza Vaccine Market Share (%), 2023

Table 01: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 02: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 03: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2019-2032

Table 04: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 05: Global Influenza Vaccine Market Revenue (USD billion) Forecast, By Region, 2019-2032

Table 06: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 07: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 08: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2019-2032

Table 09: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 10: North America Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 11: U.S. Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 12: Canada Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 13: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 14: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 15: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2019-2032

Table 16: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 17: Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 18: Germany Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 19: U.K. Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 20: France Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 21: Italy Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 22: Spain Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 23: Scandinavia Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 24: Rest of Europe Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 25: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 26: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 27: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2019-2032

Table 28: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 29: Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 30: Japan Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 31: Korea Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 32: China Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 33: India Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 34: Australia Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 35: Rest of Asia Pacific Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 36: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 37: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 38: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2019-2032

Table 39: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 40: Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 41: Brazil Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 42: Mexico Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 43: Rest of Latin America Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 44: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Type, 2019-2032

Table 45: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 46: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Age Group, 2019-2032

Table 47: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Distribution Channel, 2019-2032

Table 48: Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Country, 2019-2032

Table 49: GCC Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 50: South Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Table 51: Rest of Middle East & Africa Influenza Vaccine Market Revenue (USD billion) Forecast, By Valency, 2019-2032

Influenza Vaccine Market Size, Share and Global Industry Trend Forecast till 2032
  • 2019-2032
  • 2023
  • 2019-2022
  • 177
  • Buy Now

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Related Reports

Client Testimonials

“We are quite happy with the methodology you outlined. We really appreciate the time your team has spent on this project, and the efforts of your team to answer our questions.”

- One of the largest & renowned medical research centers based in the U.S. on a report on the U.S. NIPT Market.

“Thanks a million. The report looks great!”

- Feedback from a consultant on a report on the U.S. Beef Market.

“Thanks for the excellent report and the insights regarding the lactose market.”

- Brazil based company specializing in production of protein ingredients.

“I liked the report; would it be possible to send me the PPT version as I want to use a few slides in an internal presentation that I am preparing.”

- Global Digital Services Agency on a report on the Global Luxury Goods Market.

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X